Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 3 days ago

Vera Therapeutics, Inc.: Deep Track Capital, LP amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Deep Track Capital, LP amended its Schedule 13G stake filing for Vera Therapeutics, Inc., disclosing the change to the SEC under accession number 0001172661-26-005080. The filing updates the investment firm's previously reported beneficial ownership position in the clinical-stage biotech. The amendment signals a shift in Deep Track's holdings, though the filing itself does not specify the direction or size of the change. Investors will watch for further 13G or 13D filings to gauge whether the firm is building or trimming its position.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Vera Therapeutics, Inc., Deep Track Capital, LP